Clinical Trials on Impaired Glucose Metabolism in New Zealand
Total 5398 results
-
Columbia UniversityCompletedBody Weight | Impaired Glucose Tolerance in ObeseUnited States
-
Albert Einstein College of MedicineAmerican Diabetes AssociationCompletedImpaired Glucose ToleranceUnited States
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedT2D | IGT - Impaired Glucose ToleranceUnited States
-
Yale UniversityNational Institutes of Health (NIH); National Center for Research Resources...CompletedImpaired Glucose ToleranceUnited States
-
University of New HampshireRecruitingObesity | Insulin Resistance | Impaired Glucose Tolerance | Metabolic DisturbanceUnited States
-
OrsoBio, IncRecruitingInsulin ResistanceNew Zealand
-
University of Auckland, New ZealandCompleted
-
NovartisCompletedPrediabetic StateUnited States
-
Christchurch Women's HospitalCompletedHyperglycaemiaNew Zealand
-
Forest LaboratoriesCompleted
-
Edgar National Centre for Diabetes ResearchCompletedInsulin ResistanceNew Zealand
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsCompletedHyperglycemiaSingapore, United Kingdom, New Zealand
-
Arete TherapeuticsCompletedHypertension | Impaired Glucose ToleranceUnited States
-
Insulet CorporationCompleted
-
North Shore Hospital, New ZealandCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Zhejiang Doer Biologics Co., Ltd.RecruitingHealthy, Obesity, MetabolicallyNew Zealand
-
Diatranz Otsuka LimitedCompleted
-
University of OtagoEdgar National Centre for Diabetes ResearchCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Edgar National Centre for Diabetes ResearchUniversity of OtagoUnknown
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Christchurch HospitalUnknownDiabetes Mellitus, Type 2New Zealand
-
The University of Texas Health Science Center at...University of Texas; Takeda Pharmaceuticals North America, Inc.CompletedType 2 Diabetes | Impaired Glucose ToleranceUnited States
-
Gilead SciencesCompletedHIVUnited States, New Zealand
-
Yale UniversityCompletedObesity | Type 2 Diabetes Mellitus | Impaired Glucose ToleranceUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedCardiovascular Disease | Insulin Resistance | Pediatric Obesity | Impaired Glucose ToleranceUnited States
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompleted
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMetabolic Syndrome | Insulin Resistance | Childhood Obesity | Impaired Glucose Tolerance | Pre-diabetesUnited States
-
vTv TherapeuticsTerminatedAlzheimer DiseaseUnited States, Canada
-
Arcturus Therapeutics, Inc.CompletedOrnithine Transcarbamylase DeficiencyNew Zealand
-
Gilead SciencesCompletedInflammatory DiseaseUnited States, New Zealand, Germany
-
Bispebjerg HospitalCompleted
-
Arthrosi TherapeuticsCompletedGout PatientsNew Zealand
-
National Institute of Diabetes and Digestive and...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedImpaired Glucose Tolerance | High Risk | Autoantibody Positive | Non-diabetic Relatives at Risk for Type 1 DiabetesUnited States, Canada, Germany
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
Melbourne HealthCompletedType 1 DiabetesAustralia, New Zealand
-
Eli Lilly and CompanyCompletedType 2 DiabetesIndia, Mexico, New Zealand, South Africa
-
Rockefeller UniversityCompletedGlucose Metabolism DisorderUnited States
-
Anne Birgitte RabenUniversity of Nottingham; University of Helsinki; Wageningen University; University... and other collaboratorsCompletedObesity | Pre-diabetesSpain, Denmark, Australia, Bulgaria, Finland, Netherlands, New Zealand, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Yale UniversityCompletedGlucose IntoleranceUnited States
-
Maimonides Medical CenterCompletedImpaired ThermoregulationUnited States
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 Diabetes Mellitus | Obesity, Childhood | Impaired Glucose Tolerance | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Dartmouth-Hitchcock Medical CenterTrustees of Dartmouth CollegeWithdrawnCystic Fibrosis-related Diabetes | Cystic Fibrosis Liver Disease | CF - Cystic FibrosisUnited States
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...SuspendedDiabetes Mellitus, Type 2 | Glucose, High Blood | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHypoglycemiaUnited States
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand